VIA
BVS icon

Vident Investment Advisory’s Bioventus BVS Stock Holding History

Vident Investment Advisory’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,779
Closed -$89K – 1196
2022
Q3 		$89K Buy
12,779
+1,279
+11% +$10K ﹤0.01% 1072
2022
Q2 		$78K Buy
11,500
+567
+5% +$5.79K ﹤0.01% 1214
2022
Q1 		$154K Sell
10,933
-2,234
-17% -$29.9K ﹤0.01% 1213
2021
Q4 		$191K Buy
+13,167
New +$187K 0.01% 1137

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Vident Investment Advisory's BVS Position: Q4 2022 in Review

Vident Investment Advisory sold out of Bioventus (BVS) in Q4 2022, closing a stake of 12,779 shares — an estimated $89K sold.

Vident Investment Advisory first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $191K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Vident Investment Advisory reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 12,779 Bioventus shares in Q4 2022, an estimated $89K.
  • Vident Investment Advisory first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • Vident Investment Advisory's Bioventus position peaked at $191K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.